Back to Search Start Over

Amgen settles improper marketing claims

Source :
Long Island Business News. December 20, 2012
Publication Year :
2012

Abstract

Byline: Claude Solnik Pharmaceuticals firm Amgen has agreed to pay a $762 million to settle charges that it manipulated prices and marketed a wide range of medications beyond their uses [...]

Details

Language :
English
ISSN :
08944806
Database :
Gale General OneFile
Journal :
Long Island Business News
Publication Type :
Periodical
Accession number :
edsgcl.313024807